The FDA has stated that compounded BPC-157 may present immunogenicity and peptide-characterization risks and that available safety information is insufficient to determine whether proposed uses could harm humans
[1] Second, adverse events, predominantly gastrointestinal, were common: they occurred in roughly 91% of survodutide recipients versus 75% of placebo recipients, with gastrointestinal events specifically in about 75% of survodutide recipients versus 42% on placebo
Serum zinc levels correlated significantly negatively with IL-6, IL-4 and IL-17 [98]
Shoes with rigid, enclosed heel counters dress shoes, certain running shoes fresh out of the box, stiff hiking boots press directly against the subcutaneous calcaneal bursa, the shallower one sitting just under your skin
Even with less-than-expected weight loss, patients with lipedema should still be considered candidates for bariatric surgery as several procedures (e.g., laparoscopic gastric bypass and sleeve gastrectomy) have shown weight-independent benefits on glucometabolic outcomes, especially prediabetes and diabetes, and cardiovascular risk
Higher doses increase peptide consumption and cost without guaranteed proportional benefit increases